Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 700
- Avg volume
- —
- Day's range
- $0.03 – $0.04
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.
- Industry
- Medical Devices
- Sector
- Healthcare
- Website
- https://www.vvtmed.com
- Address
- Hasadna 6 st., Kfar Saba, Israel
Latest news
No headlines yet.
